vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.
RANGE RESOURCES CORP is the larger business by last-quarter revenue ($786.9M vs $451.8M, roughly 1.7× HALOZYME THERAPEUTICS, INC.). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs -31.3%, a 54.1% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 18.0%). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 14.6%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.
HALO vs RRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $786.9M |
| Net Profit | $-141.6M | $179.1M |
| Gross Margin | 82.6% | 94.5% |
| Operating Margin | -20.6% | — |
| Net Margin | -31.3% | 22.8% |
| Revenue YoY | 51.6% | 18.0% |
| Net Profit YoY | -203.3% | 88.8% |
| EPS (diluted) | $-1.13 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $786.9M | ||
| Q3 25 | $354.3M | $655.3M | ||
| Q2 25 | $325.7M | $699.6M | ||
| Q1 25 | $264.9M | $846.3M | ||
| Q4 24 | $298.0M | $667.0M | ||
| Q3 24 | $290.1M | $567.9M | ||
| Q2 24 | $231.4M | $513.2M | ||
| Q1 24 | $195.9M | $598.8M |
| Q4 25 | $-141.6M | $179.1M | ||
| Q3 25 | $175.2M | $144.3M | ||
| Q2 25 | $165.2M | $237.6M | ||
| Q1 25 | $118.1M | $97.1M | ||
| Q4 24 | $137.0M | $94.8M | ||
| Q3 24 | $137.0M | $50.7M | ||
| Q2 24 | $93.2M | $28.7M | ||
| Q1 24 | $76.8M | $92.1M |
| Q4 25 | 82.6% | 94.5% | ||
| Q3 25 | 84.4% | 92.5% | ||
| Q2 25 | 85.8% | 95.0% | ||
| Q1 25 | 81.7% | 93.1% | ||
| Q4 24 | 85.9% | 93.7% | ||
| Q3 24 | 83.0% | 94.3% | ||
| Q2 24 | 82.9% | 93.4% | ||
| Q1 24 | 85.5% | 94.7% |
| Q4 25 | -20.6% | — | ||
| Q3 25 | 61.5% | — | ||
| Q2 25 | 62.2% | — | ||
| Q1 25 | 53.4% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 50.7% | — | ||
| Q1 24 | 48.8% | — |
| Q4 25 | -31.3% | 22.8% | ||
| Q3 25 | 49.5% | 22.0% | ||
| Q2 25 | 50.7% | 34.0% | ||
| Q1 25 | 44.6% | 11.5% | ||
| Q4 24 | 46.0% | 14.2% | ||
| Q3 24 | 47.2% | 8.9% | ||
| Q2 24 | 40.3% | 5.6% | ||
| Q1 24 | 39.2% | 15.4% |
| Q4 25 | $-1.13 | $0.75 | ||
| Q3 25 | $1.43 | $0.60 | ||
| Q2 25 | $1.33 | $0.99 | ||
| Q1 25 | $0.93 | $0.40 | ||
| Q4 24 | $1.06 | $0.38 | ||
| Q3 24 | $1.05 | $0.21 | ||
| Q2 24 | $0.72 | $0.12 | ||
| Q1 24 | $0.60 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $204.0K |
| Total DebtLower is stronger | $2.1B | $1.2B |
| Stockholders' EquityBook value | $48.8M | $4.3B |
| Total Assets | $2.5B | $7.4B |
| Debt / EquityLower = less leverage | 43.89× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $204.0K | ||
| Q3 25 | $419.7M | $175.0K | ||
| Q2 25 | $61.9M | $134.0K | ||
| Q1 25 | $176.3M | $344.6M | ||
| Q4 24 | $115.8M | $304.5M | ||
| Q3 24 | $154.3M | $277.4M | ||
| Q2 24 | $187.9M | $251.1M | ||
| Q1 24 | $164.6M | $343.1M |
| Q4 25 | $2.1B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.7B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $1.5B | $1.7B | ||
| Q1 24 | $1.5B | $1.8B |
| Q4 25 | $48.8M | $4.3B | ||
| Q3 25 | $503.9M | $4.2B | ||
| Q2 25 | $332.7M | $4.1B | ||
| Q1 25 | $482.3M | $3.9B | ||
| Q4 24 | $363.8M | $3.9B | ||
| Q3 24 | $452.7M | $3.9B | ||
| Q2 24 | $289.4M | $3.9B | ||
| Q1 24 | $177.8M | $3.8B |
| Q4 25 | $2.5B | $7.4B | ||
| Q3 25 | $2.2B | $7.2B | ||
| Q2 25 | $2.1B | $7.1B | ||
| Q1 25 | $2.2B | $7.4B | ||
| Q4 24 | $2.1B | $7.3B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.0B | $7.3B | ||
| Q1 24 | $1.8B | $7.4B |
| Q4 25 | 43.89× | 0.28× | ||
| Q3 25 | 3.00× | 0.29× | ||
| Q2 25 | 4.54× | 0.29× | ||
| Q1 25 | 3.13× | 0.43× | ||
| Q4 24 | 4.14× | 0.43× | ||
| Q3 24 | 3.32× | 0.44× | ||
| Q2 24 | 5.19× | 0.44× | ||
| Q1 24 | 8.44× | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $257.5M |
| Free Cash FlowOCF − Capex | $217.6M | — |
| FCF MarginFCF / Revenue | 48.2% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $257.5M | ||
| Q3 25 | $178.6M | $247.5M | ||
| Q2 25 | $99.7M | $336.2M | ||
| Q1 25 | $154.2M | $330.1M | ||
| Q4 24 | $178.5M | $217.9M | ||
| Q3 24 | $115.4M | $245.9M | ||
| Q2 24 | $55.8M | $148.8M | ||
| Q1 24 | $129.4M | $331.9M |
| Q4 25 | $217.6M | — | ||
| Q3 25 | $175.6M | — | ||
| Q2 25 | $98.1M | — | ||
| Q1 25 | $153.3M | — | ||
| Q4 24 | $175.4M | — | ||
| Q3 24 | $113.9M | — | ||
| Q2 24 | $53.2M | — | ||
| Q1 24 | $125.9M | — |
| Q4 25 | 48.2% | — | ||
| Q3 25 | 49.6% | — | ||
| Q2 25 | 30.1% | — | ||
| Q1 25 | 57.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 39.3% | — | ||
| Q2 24 | 23.0% | — | ||
| Q1 24 | 64.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | — | 1.44× | ||
| Q3 25 | 1.02× | 1.72× | ||
| Q2 25 | 0.60× | 1.42× | ||
| Q1 25 | 1.31× | 3.40× | ||
| Q4 24 | 1.30× | 2.30× | ||
| Q3 24 | 0.84× | 4.85× | ||
| Q2 24 | 0.60× | 5.18× | ||
| Q1 24 | 1.68× | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
